Format

Send to

Choose Destination
See comment in PubMed Commons below
Klin Padiatr. 1998 Jul-Aug;210(4):153-8.

[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].

[Article in German]

Author information

1
Universitäts-Kinderklinik Ulm, Germany.

Abstract

CD95 (APO-1/Fas)-mediated apoptosis plays a major role in normal lymphocyte regulation. CD95 mutations cause a benign autoimmune lymphoproliferation syndrome (ALPS) in mice and humans. CD95 is mutated in some de novo T-lineage acute lymphoblastic leukemia of childhood and these mutations might be of biological significance. The resistance toward CD95-mediated apoptosis observed in most B-lineage ALL is not caused by mutations of CD95. CD95 mutations have been associated with Hodgkin's and Non-Hodgkin's lymphoma and have been described in multiple myeloma. The relevance of CD95 mutations for chemoresistance of ALL requires further study.

PMID:
9743945
DOI:
10.1055/s-2008-1043871
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Support Center